Latest News about ALNY

Recent news which mentions ALNY

...

4 5 6 7 8 9 10 11 Next >

Alnylam - Regeneron Partnered Alzheimer's Candidate's Initial Data Sounds Promising, Analyst Says

April 27, 2023

3 Pharma Stocks That Could See a Surge in Demand in 2023

April 24, 2023

How To Attend Alnylam Pharmaceuticals Q1 2023 Earnings Conference Call

April 21, 2023

10 Health Care Stocks With Whale Alerts In Today's Session

April 19, 2023

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today

April 17, 2023

Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'

April 12, 2023

A Bearish Sign Appears On Alnylam Pharmaceuticals's Chart

April 11, 2023

Here's How Much $100 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today

April 05, 2023

Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots

April 04, 2023

Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023

March 21, 2023

Analyst Ratings for Alnylam Pharmaceuticals

March 21, 2023

3 Growth Stocks That Could Disrupt the Healthcare Industry

March 13, 2023

Looking Into Alnylam Pharmaceuticals's Recent Short Interest

March 03, 2023

Alnylam Pharmaceuticals's Return On Capital Employed Insights

February 27, 2023

Analyst Ratings for Alnylam Pharmaceuticals

February 24, 2023

Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023

February 21, 2023

Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023

January 18, 2023

3 Growth Stocks That Could Rocket Higher in 2023

January 06, 2023

Meta To Rally Over 29%? Here Are 10 Other Price Target Changes For Friday

December 16, 2022

Pfizer, BioNTech Fire Back At Moderna Over COVID-19 Vaccine Related Patent Claims

December 06, 2022

Looking Into Alnylam Pharmaceuticals's Return On Capital Employed

November 02, 2022

What 11 Analyst Ratings Have To Say About Alnylam Pharmaceuticals

November 02, 2022

Alnylam Scraps Interim Analysis For Heart Disease Trial, Rethinks Plans For Another Rare Disorder Program

October 27, 2022

Alnylam Pharmaceuticals: Q3 Earnings Insights

October 27, 2022

Quant Ratings Updated on 77 Stocks

October 18, 2022

Where Alnylam Pharmaceuticals Stands With Analysts

October 13, 2022

Roblox To $51? Plus Deutsche Bank Slashes PT On Deere & Company

October 13, 2022

3 Top Biotech Stocks Defying the Bear Market

October 11, 2022

Alnylam's Lumasiran Scores Expanded FDA Approval For Ultra Rare Genetic Disease

October 07, 2022

Where Alnylam Pharmaceuticals Stands With Analysts

October 03, 2022

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.